| Literature DB >> 35464598 |
Faisal K Alrasheed1, Yazeed A Alowairdhi1, Yasser M Alkharashi1, Abdulrahman O Alomar1, Muhannad Q Alqirnas1, Nawaf A Alhussaini1, Abdulrahman Albassam1, Abdulaziz S Almosa1, Ahmed Z Alkhars2, Mohammed Alhelail1,3,4.
Abstract
Background There has been a tremendous increase in self-poisoning behavior worldwide, with different trends depending on cultural and geographic aspects. Objectives Our study aims to assess the trends, outcomes, and predictors in patients of suicide attempts by poisoning at King Abdulaziz Medical City (KAMC) ED. Materials and methods A retrospective cohort study took place at KAMC. Frequencies and percentages were used to display categorical variables. Minimum, maximum, mean, and SD were used to display continuous variables. Chi-squared test and independent t-test were utilized to test for factors associated with suicidal intention. Results A total of 130 cases were identified. The participants were mostly females (73.8%, n = 96). Most of the participants were pediatric patients (57.7%, n = 75). The most consumed agents were acetaminophen in 59 (45.83%) and non-steroidal anti-inflammatory drugs (NSAIDs) in 22 (16.92%). The ICU admission rate was 8.5% (n = 11). The management for both populations was unspecific, involving observation, supportive measures, and symptomatic treatment. BMI (p < 0.001), gender (p < 0.001), age (p = 0.012), and a history of neuropsychiatric disorders (p < 0.001) were associated factors. Conclusion It is crucial that the trends and risk factors of self-poisoning suicide attempts are identified to provide support to those in need. Several variables of interest were noted since the two most observed agents share several key features, such as accessibility and availability. However, contradicting literature reports warrant further investigation to confirm or negate the evidence.Entities:
Keywords: emergency medicine; poisoning; saudi arabia; suicide; suicidology; toxicology
Year: 2022 PMID: 35464598 PMCID: PMC9015061 DOI: 10.7759/cureus.23330
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Poisoning history.
| Poisoning History (n = 492) | n | % |
| Number of poisoning agents | ||
| 1 | 79 | 60.8 |
| 2 | 34 | 26.2 |
| 3 | 9 | 6.9 |
| 4 | 5 | 3.8 |
| 5 | 1 | 0.8 |
| 6 | 1 | 0.8 |
| 9 | 1 | 0.8 |
| Premature discharge | ||
| No | 127 | 97.7 |
| Yes | 3 | 2.3 |
| Outcome | ||
| Good | 119 | 91.5 |
| ICU admission | 11 | 8.5 |
| Length of stay (in days) | ||
| Mean | 2.06 | |
| SD | 2.89 | |
| Minimum | 0.17 | |
| Maximum | 29 | |
Ingested agents.
| Ingested Agents | n | % | Ingested Agents | n | % | |
| Acetaminophen | 59 | 45.38 | Estrogen | 1 | 0.77 | |
| Amphetamine | 1 | 0.77 | Guaifenesin | 2 | 1.54 | |
| Antibiotic | 13 | 10.00 | Herbal | 2 | 1.54 | |
| Anticholinergic | 1 | 0.77 | Immunosuppressant | 1 | 0.77 | |
| Anticoagulant | 2 | 1.54 | Laxative | 1 | 0.77 | |
| Anticonvulsant | 11 | 8.46 | Minerals | 7 | 5.38 | |
| Antidepressant | 1 | 0.77 | Miscellaneous | 3 | 2.31 | |
| Antidiabetic | 8 | 6.15 | Muscle relaxant | 5 | 3.85 | |
| Antiemetic | 2 | 1.54 | Non-steroidal anti-inflammatory drugs | 22 | 16.92 | |
| Antihistamine | 10 | 7.69 | Organophosphate | 2 | 1.54 | |
| Antiplatelet | 1 | 0.77 | Proton pump inhibitor | 5 | 3.85 | |
| Antithyroid | 1 | 0.77 | Pseudoephedrine | 3 | 2.31 | |
| Atypical antipsychotic | 9 | 6.92 | Salicylate | 6 | 4.62 | |
| Beta2-agonist | 1 | 0.77 | Simethicone | 1 | 0.77 | |
| Beta-blocker | 2 | 1.54 | Selective serotonin reuptake inhibitors | 8 | 6.15 | |
| Benzodiazepine | 2 | 1.54 | Statin | 3 | 2.31 | |
| Calcium channel blockers | 1 | 0.77 | Steroid | 1 | 0.77 | |
| Central nervous system stimulant | 2 | 1.54 | Tricyclic anti-depressants | 1 | 0.77 | |
| Dextromethorphan | 2 | 1.54 | Unknown agent | 2 | 1.54 | |
| Disinfectant | 5 | 3.85 | Vitamins | 5 | 3.85 | |
| Diuretic | 1 | 0.77 | ||||
Key interventions received by the participants during their admission.
| Intervention | n | % |
| Observation, supportive management, and admission | ||
| Total | 101 | 77.69 |
| Admission | 12 | 9.23 |
| Observation and reassurance | 65 | 50.00 |
| Supportive and symptomatic management | 24 | 18.46 |
| Decontamination and elimination | ||
| Total | 8 | 6.15 |
| Activated charcoal | 6 | 4.62 |
| Decontamination | 1 | 0.77 |
| Gastric lavage | 1 | 0.77 |
| Lipid emulsion | 1 | 0.77 |
| Antidotal and targeted therapy | ||
| Total | 28 | 21.54 |
| Benzodiazepine | 2 | 1.54 |
| Benztropine (anticholinergics) | 1 | 0.77 |
| Deferoxamine | 1 | 0.77 |
| Ketamine | 1 | 0.77 |
| Midazolam | 2 | 1.54 |
| N-Acetylcysteine | 14 | 10.77 |
| Naloxone | 2 | 1.54 |
| Proton pump inhibitor | 2 | 1.54 |
| Ranitidine | 1 | 0.77 |
| Sodium Bicarbonate | 1 | 0.77 |
| Vitamin K | 1 | 0.77 |
| Blood and blood products | ||
| Total | 1 | 0.77 |
| Fresh frozen plasma | 1 | 0.77 |
| Miscellaneous | ||
| Total | 7 | 5.38 |
| Intubation | 2 | 1.54 |
| Not documented | 5 | 3.85 |
Presenting complaints of poisoning.
| Presenting Complaints of Poisoning (n = 130) | n | % |
| Clinical presentation | ||
| Abdominal pain | 36 | 27.69 |
| Agitation | 4 | 3.08 |
| Altered level of consciousness | 23 | 17.69 |
| Asymptomatic | 28 | 21.54 |
| Bleeding | 1 | 0.77 |
| Chest pain | 5 | 3.85 |
| Diaphoresis | 1 | 0.77 |
| Diarrhea | 1 | 0.77 |
| Dizziness | 15 | 11.54 |
| Dystonic reaction (dyskinesia) | 1 | 0.77 |
| Generalized weakness (lethargy) | 2 | 1.54 |
| Hallucinations | 2 | 1.54 |
| Headache | 6 | 4.62 |
| Nausea | 12 | 9.23 |
| Palpitation (tachycardia) | 8 | 6.15 |
| Paresthesia | 2 | 1.54 |
| Rash | 1 | 0.77 |
| Restless | 1 | 0.77 |
| Shivering | 2 | 1.54 |
| Shortness of breath | 5 | 3.85 |
| Tinnitus | 1 | 0.77 |
| Tremor | 1 | 0.77 |
| Urine incontinence | 1 | 0.77 |
| Visual disturbance (diplopia) | 3 | 2.31 |
| Vomiting | 43 | 33.08 |
| Not documented | 1 | 0.77 |
Factors associated with suicide using poisoning.
* represents p < 0.05.
| Factors Associated with Suicide Using Poisoning | ||||
| Factor | Suicide | P-Value | ||
| Yes | No | |||
| BMI (mean, SD) | 22.39 + 8.94 | 19.33 + 7.42 | < 0.001* | |
| Number of comorbidities (mean, SD) | 1.1 + 0.41 | 1.15 + 0.58 | 0.347 | |
| Gender | < 0.001* | |||
| Male | 33 (4.1%) | 770 (95.9%) | ||
| Female | 96 (13.7%) | 606 (86.3%) | ||
| Age group | 0.012* | |||
| Pediatric | 74 (7.3%) | 939 (92.7%) | ||
| Adults | 55 (11.2%) | 437 (88.8%) | ||
| Medical history | 0.267 | |||
| Have a chronic disease | 37 (10%) | 334 (90%) | ||
| Medically free | 92 (8.1%) | 1042 (91.9%) | ||
| Neuropsychiatric disorders | <0.001* | |||
| Yes | 26 (20.5%) | 101 (79.5%) | ||
| No | 103 (7.5%) | 1275 (92.5%) | ||
| *Significant at level 0.05 | ||||